Kirkland Represents Airdoc on Series D Financing Round

Kirkland & Ellis advised Beijing Airdoc Technology Co., Ltd., a global market leader and pioneer in providing AI-empowered retina-based early detection, diagnosis and health risk assessment solutions, on the successful completion of its Series D financing. Lilly Asia Ventures, Lake Bleu Capital and OrbiMed jointly participated in this investment.

Read the Airdoc press release

The Kirkland team was led by capital markets partner Dr. Mengyu Lu.